Skip to main content
Top
Published in: The International Journal of Cardiovascular Imaging 3/2024

27-12-2023 | Atrial Fibrillation | Original Paper

The value of serial echocardiography in risk assessment of patients with paroxysmal atrial fibrillation

Authors: Melissa Leung, Philippe J. van Rosendael, Pieter van der Bijl, Madelien V. Regeer, Suzanne E. van Wijngaarden, Dominic Y. Leung, Victoria Delgado, Nina Ajmone Marsan, Arnold C. T. Ng, Jeroen J. Bax

Published in: The International Journal of Cardiovascular Imaging | Issue 3/2024

Login to get access

Abstract

Progression from paroxysmal to persistent atrial fibrillation (AF) is associated with increased morbidity and mortality. We examined the association of left atrial (LA) remodeling by serial echocardiography, and AF progression over an extended follow-up period. Two-hundred ninety patients (mean age 61  ±  11 years, 73% male) who underwent transthoracic echocardiography performed at first presentation for non-valvular paroxysmal AF (PAF) and repeat echocardiogram 1-year later, were followed for progression to persistent AF. LA and left ventricular (LV) dimensions, volumes, LA reservoir, conduit and booster pump strains, LV global longitudinal systolic strain (GLS) assessed by 2D speckle tracking, and PA-TDI (time delay between electrical and mechanical LA activation– reflecting the extent of LA fibrosis) were compared on serial echocardiography. Sixty-nine (24%) patients developed persistent AF over a mean follow-up period of 6.3 years. At baseline, patients with subsequent persistent AF had larger LA dimensions (46 mm vs. 42 mm, p < 0.001), indexed LA volumes (41 ml/m2 vs. 34 ml/m2, p < 0.001), lower LA reservoir and conduit strain (17.6% vs. 27.6%, p < 0.001; 10.5% vs. 16.3%, p < 0.001; respectively) and longer PA-TDI (155 ms vs. 132 ms, p < 0.001) compared to the PAF group. Patients with subsequent persistent AF showed over time significant enlargement in LA volumes (from 37.7 ml/m2 to 42.4 ml/m2, p < 0.001), lengthening of PA-TDI (from 142.2 ms to 162.2 ms, p = 0.002), and decline in LA reservoir function (from 21.9% to 18.1%, p = 0.024) after adjusting for age, gender, diabetes and LV GLS. There were no changes in LA diameter, LA conduit or booster pump function. Conversely, the PAF group showed no decline in LA function. Patients who developed persistent AF had larger LA size and impaired LA function and atrial conduction times at baseline, compared to patients who remained PAF. Over the 1-year time course of serial echocardiographic evaluation, there was progression of LA remodeling in patients who subsequently developed persistent AF, but not in patients who remained in PAF.
Literature
1.
go back to reference Kannel WB et al (1982) Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 306(17):1018–1022PubMedCrossRef Kannel WB et al (1982) Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 306(17):1018–1022PubMedCrossRef
2.
go back to reference Steinberg BA et al (2015) Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial. Eur Heart J 36:288–296PubMedCrossRef Steinberg BA et al (2015) Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial. Eur Heart J 36:288–296PubMedCrossRef
3.
go back to reference Benjamin EJ et al (1998) Impact of atrial fibrillation on the risk of death the Framingham Heart Study. Circulation 98(10):946–952PubMedCrossRef Benjamin EJ et al (1998) Impact of atrial fibrillation on the risk of death the Framingham Heart Study. Circulation 98(10):946–952PubMedCrossRef
4.
go back to reference Wang M et al (2003) Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value. J Am Coll Cardiol 41(5):820–826PubMedCrossRef Wang M et al (2003) Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value. J Am Coll Cardiol 41(5):820–826PubMedCrossRef
5.
go back to reference Hart RG et al (2000) Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. J Am Coll Cardiol 35(1):183–187PubMedCrossRef Hart RG et al (2000) Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. J Am Coll Cardiol 35(1):183–187PubMedCrossRef
6.
go back to reference Hohnloser SH et al (2007) Incidence of stroke in Paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W substudy. J Am Coll Cardiol 50(22):2156–2161PubMedCrossRef Hohnloser SH et al (2007) Incidence of stroke in Paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W substudy. J Am Coll Cardiol 50(22):2156–2161PubMedCrossRef
7.
go back to reference van Walraven C et al (2002) Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA 288(19):2441–2448PubMedCrossRef van Walraven C et al (2002) Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA 288(19):2441–2448PubMedCrossRef
8.
go back to reference Hart RG, Pearce LA, Aguilar MI (2007) Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146(12):857–867PubMedCrossRef Hart RG, Pearce LA, Aguilar MI (2007) Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146(12):857–867PubMedCrossRef
9.
go back to reference Connolly SJ et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361(12):1139–1151PubMedCrossRef Connolly SJ et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361(12):1139–1151PubMedCrossRef
10.
go back to reference Patel MR et al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365(10):883–891PubMedCrossRef Patel MR et al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365(10):883–891PubMedCrossRef
11.
go back to reference de Vos CB et al (2010) Progression from paroxysmal to persistent atrial fibrillation: clinical correlates and prognosis. J Am Coll Cardiol 55(8):725–731PubMedCrossRef de Vos CB et al (2010) Progression from paroxysmal to persistent atrial fibrillation: clinical correlates and prognosis. J Am Coll Cardiol 55(8):725–731PubMedCrossRef
12.
go back to reference Link MS et al (2017) Stroke and mortality risk in patients with various patterns of atrial fibrillation: results from the ENGAGE AF-TIMI 48 trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48). Circ Arrhythmia Electrophysiol 10(1):e004267CrossRef Link MS et al (2017) Stroke and mortality risk in patients with various patterns of atrial fibrillation: results from the ENGAGE AF-TIMI 48 trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48). Circ Arrhythmia Electrophysiol 10(1):e004267CrossRef
13.
go back to reference Steinberg BA et al (2015) Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial. Eur Heart J 36(5):288–296PubMedCrossRef Steinberg BA et al (2015) Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial. Eur Heart J 36(5):288–296PubMedCrossRef
14.
go back to reference Go AS et al (2018) Association of burden of atrial fibrillation with risk of ischemic stroke in adults with paroxysmal atrial fibrillation: the KP-RHYTHM study. JAMA Cardiolo 3(7):601–608CrossRef Go AS et al (2018) Association of burden of atrial fibrillation with risk of ischemic stroke in adults with paroxysmal atrial fibrillation: the KP-RHYTHM study. JAMA Cardiolo 3(7):601–608CrossRef
15.
go back to reference Leung M et al (2018) The impact of atrial fibrillation clinical subtype on mortality. JACC: Clin Electrophysiol 4(2):221–227PubMed Leung M et al (2018) The impact of atrial fibrillation clinical subtype on mortality. JACC: Clin Electrophysiol 4(2):221–227PubMed
16.
go back to reference den Uijl DW et al (2011) Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation. Heart 97(22):1847–1851CrossRef den Uijl DW et al (2011) Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation. Heart 97(22):1847–1851CrossRef
17.
go back to reference Hwang HJ et al (2009) Left atrial strain as predictor of successful outcomes in catheter ablation for atrial fibrillation: a two-dimensional myocardial imaging study. J Interv Card Electrophysiol 26(2):127–132PubMedCrossRef Hwang HJ et al (2009) Left atrial strain as predictor of successful outcomes in catheter ablation for atrial fibrillation: a two-dimensional myocardial imaging study. J Interv Card Electrophysiol 26(2):127–132PubMedCrossRef
18.
go back to reference Yoon YE et al (2015) Echocardiographic predictors of progression to persistent or permanent atrial fibrillation in patients with paroxysmal atrial fibrillation (E6P study). J Am Soc Echocardiogr 28(6):709–717PubMedCrossRef Yoon YE et al (2015) Echocardiographic predictors of progression to persistent or permanent atrial fibrillation in patients with paroxysmal atrial fibrillation (E6P study). J Am Soc Echocardiogr 28(6):709–717PubMedCrossRef
19.
go back to reference Kerr CR et al (2005) Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. Am Heart J 149(3):489–496PubMedCrossRef Kerr CR et al (2005) Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. Am Heart J 149(3):489–496PubMedCrossRef
20.
go back to reference Suzuki T et al (2011) Echocardiographic predictors of frequency of paroxysmal atrial fibrillation (AF) and its progression to persistent AF in hypertensive patients with paroxysmal AF: results from the Japanese Rhythm Management Trial II for Atrial Fibrillation (J-RHYTHM II Study). Heart Rhythm 8(12):1831–1836PubMedCrossRef Suzuki T et al (2011) Echocardiographic predictors of frequency of paroxysmal atrial fibrillation (AF) and its progression to persistent AF in hypertensive patients with paroxysmal AF: results from the Japanese Rhythm Management Trial II for Atrial Fibrillation (J-RHYTHM II Study). Heart Rhythm 8(12):1831–1836PubMedCrossRef
21.
go back to reference Kuppahally SS et al (2010) Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: relationship to left atrial structural remodeling detected by delayed-enhancement MRI. Circ Cardiovasc Imaging 3(3):231–239PubMedCrossRef Kuppahally SS et al (2010) Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: relationship to left atrial structural remodeling detected by delayed-enhancement MRI. Circ Cardiovasc Imaging 3(3):231–239PubMedCrossRef
22.
go back to reference Platonov PG et al (2011) Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. J Am Coll Cardiol 58(21):2225–2232PubMedCrossRef Platonov PG et al (2011) Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. J Am Coll Cardiol 58(21):2225–2232PubMedCrossRef
23.
go back to reference Teh AW et al (2012) Long-term effects of catheter ablation for lone atrial fibrillation: progressive atrial electroanatomic substrate remodeling despite successful ablation. Heart Rhythm 9(4):473–480PubMedCrossRef Teh AW et al (2012) Long-term effects of catheter ablation for lone atrial fibrillation: progressive atrial electroanatomic substrate remodeling despite successful ablation. Heart Rhythm 9(4):473–480PubMedCrossRef
24.
go back to reference Oakes RS et al (2009) Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation 119(13):1758–1767PubMedPubMedCentralCrossRef Oakes RS et al (2009) Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation 119(13):1758–1767PubMedPubMedCentralCrossRef
25.
go back to reference Mueller P et al (2013) Correlation between total atrial conduction time estimated via tissue Doppler imaging (PA-TDI Interval), structural atrial remodeling and new-onset of atrial fibrillation after cardiac surgery. J Cardiovasc Electrophysiol 24(6):626–631CrossRef Mueller P et al (2013) Correlation between total atrial conduction time estimated via tissue Doppler imaging (PA-TDI Interval), structural atrial remodeling and new-onset of atrial fibrillation after cardiac surgery. J Cardiovasc Electrophysiol 24(6):626–631CrossRef
26.
go back to reference Leung M et al (2018) Relation of echocardiographic markers of left atrial fibrosis to atrial fibrillation burden. Am J Cardiol 122(4):584–591PubMedCrossRef Leung M et al (2018) Relation of echocardiographic markers of left atrial fibrosis to atrial fibrillation burden. Am J Cardiol 122(4):584–591PubMedCrossRef
27.
go back to reference Hindricks G et al (2020) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 42(5):373–498CrossRef Hindricks G et al (2020) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 42(5):373–498CrossRef
28.
go back to reference Camm AJ et al (2010) Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31(19):2369–2429PubMedCrossRef Camm AJ et al (2010) Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31(19):2369–2429PubMedCrossRef
29.
go back to reference Lip GY et al (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest J 137(2):263–272CrossRef Lip GY et al (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest J 137(2):263–272CrossRef
30.
go back to reference Lang RM et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr 28(1):1–39PubMedCrossRef Lang RM et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr 28(1):1–39PubMedCrossRef
31.
go back to reference Mor-Avi V et al (2011) Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. Eur J Echocardiogr 12(3):167–205PubMedCrossRef Mor-Avi V et al (2011) Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. Eur J Echocardiogr 12(3):167–205PubMedCrossRef
32.
go back to reference Malavasi VL et al (2021) Atrial fibrillation pattern and factors affecting the progression to permanent atrial fibrillation. Intern Emerg Med 16:1131–1140PubMedCrossRef Malavasi VL et al (2021) Atrial fibrillation pattern and factors affecting the progression to permanent atrial fibrillation. Intern Emerg Med 16:1131–1140PubMedCrossRef
33.
go back to reference Pillarisetti J et al (2009) Evolution of paroxysmal atrial fibrillation to persistent or permanent atrial fibrillation: predictors of progression. J Atrial Fibrillation 2(1):388–394 Pillarisetti J et al (2009) Evolution of paroxysmal atrial fibrillation to persistent or permanent atrial fibrillation: predictors of progression. J Atrial Fibrillation 2(1):388–394
34.
go back to reference Su H-M et al (2013) Global left ventricular longitudinal systolic strain as a major predictor of cardiovascular events in patients with atrial fibrillation. Heart 99(21):1588–1596PubMedCrossRef Su H-M et al (2013) Global left ventricular longitudinal systolic strain as a major predictor of cardiovascular events in patients with atrial fibrillation. Heart 99(21):1588–1596PubMedCrossRef
35.
go back to reference Parkash R et al (2004) The association of left atrial size and occurrence of atrial fibrillation: a prospective cohort study from the Canadian Registry of Atrial Fibrillation. Am Heart J 148(4):649–654PubMedCrossRef Parkash R et al (2004) The association of left atrial size and occurrence of atrial fibrillation: a prospective cohort study from the Canadian Registry of Atrial Fibrillation. Am Heart J 148(4):649–654PubMedCrossRef
36.
go back to reference Leung M et al (2018) Assessing Atrial Function. In: Nihoyannopoulos P, Kisslo J (eds) Echocardiography. Springer International Publishing, Cham, pp 661–681CrossRef Leung M et al (2018) Assessing Atrial Function. In: Nihoyannopoulos P, Kisslo J (eds) Echocardiography. Springer International Publishing, Cham, pp 661–681CrossRef
37.
go back to reference Shinagawa K et al (2002) Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs. Circulation 105(22):2672–2678PubMedCrossRef Shinagawa K et al (2002) Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs. Circulation 105(22):2672–2678PubMedCrossRef
38.
go back to reference Nattel S, Burstein B, Dobrev D (2008) Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythmia Electrophysiol 1(1):62–73CrossRef Nattel S, Burstein B, Dobrev D (2008) Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythmia Electrophysiol 1(1):62–73CrossRef
39.
go back to reference Kainuma S et al (2011) Advanced left-atrial fibrosis is associated with unsuccessful maze operation for valvular atrial fibrillation. Eur J Cardiothorac Surg 40(1):61–69PubMedCrossRef Kainuma S et al (2011) Advanced left-atrial fibrosis is associated with unsuccessful maze operation for valvular atrial fibrillation. Eur J Cardiothorac Surg 40(1):61–69PubMedCrossRef
40.
go back to reference Wang TJ et al (2003) Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107(23):2920–2925PubMedCrossRef Wang TJ et al (2003) Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107(23):2920–2925PubMedCrossRef
41.
go back to reference Botto GL et al (2009) Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol 20(3):241–248PubMedCrossRef Botto GL et al (2009) Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol 20(3):241–248PubMedCrossRef
42.
go back to reference Deng H et al (2017) Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review. Clin Res Cardiol 106:813–823PubMedPubMedCentralCrossRef Deng H et al (2017) Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review. Clin Res Cardiol 106:813–823PubMedPubMedCentralCrossRef
43.
go back to reference Cosedis Nielsen J et al (2012) Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med 367(17):1587–1595PubMedCrossRef Cosedis Nielsen J et al (2012) Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med 367(17):1587–1595PubMedCrossRef
44.
go back to reference Calkins H et al (2012) 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm 9(4):632-696.e21PubMedCrossRef Calkins H et al (2012) 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm 9(4):632-696.e21PubMedCrossRef
45.
go back to reference Bollmann A (2007) Pulmonary venous flow assessed by Doppler echocardiography in the management of atrial fibrillation. Echocardiography 24(4):430–435PubMedCrossRef Bollmann A (2007) Pulmonary venous flow assessed by Doppler echocardiography in the management of atrial fibrillation. Echocardiography 24(4):430–435PubMedCrossRef
Metadata
Title
The value of serial echocardiography in risk assessment of patients with paroxysmal atrial fibrillation
Authors
Melissa Leung
Philippe J. van Rosendael
Pieter van der Bijl
Madelien V. Regeer
Suzanne E. van Wijngaarden
Dominic Y. Leung
Victoria Delgado
Nina Ajmone Marsan
Arnold C. T. Ng
Jeroen J. Bax
Publication date
27-12-2023
Publisher
Springer Netherlands
Published in
The International Journal of Cardiovascular Imaging / Issue 3/2024
Print ISSN: 1569-5794
Electronic ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-023-03014-6

Other articles of this Issue 3/2024

The International Journal of Cardiovascular Imaging 3/2024 Go to the issue